News

First App Launched to Identify Drug Shortages
news

The FDA has approved U(indacaterol and glycopyrrolate (Utibron Neohaler) and glycopyrrolate (Seebri Neohaler) for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.